| 前收市價 | 2.9500 |
| 開市 | 2.7100 |
| 買盤 | 2.4000 |
| 賣出價 | 3.1000 |
| 拍板 | 2.50 |
| 到期日 | 2024-11-15 |
| 今日波幅 | 2.7100 - 2.9500 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 81 |
ZacksEditas (EDIT) Reports Upbeat New Data From Reni-Cel Studies
Editas (EDIT) reports positive new safety and efficacy data from the RUBY and EdiTHAL studies evaluating its investigational gene therapy, reni-cel, for SCD and TDT, respectively.
ZacksEditas (EDIT) Down 2.3% Since Last Earnings Report: Can It Rebound?
Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Insider MonkeyEditas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript
Editas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript May 8, 2024 Editas Medicine, Inc. misses on earnings expectations. Reported EPS is $-0.76 EPS, expectations were $-0.63. Editas Medicine, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
